<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8 - K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 6, 1998
----------------
GALILEO CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 04-2526583
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
0-11309
(Commission File Number)
GALILEO PARK, P.O. BOX 550, STURBRIDGE, MASSACHUSETTS 01566
(Address of principal executive offices) (Zip Code)
Registrant's telephone number including area code (508) 347-9191
- -------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
Item 5. OTHER EVENTS
The Registrant reported in a press release dated November 6, 1998,
which is included in this filing as Exhibit 99.1, that discussions had
been terminated to sell certain product lines in its Scientific
Detector and Remote Spectroscopy Business because the Company and the
potential purchaser could not agree on the terms of the sale. The
Company had announced the signing of a non-binding Letter of Intent
with an undisclosed potential purchaser on August 19, 1998.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
a) Exhibit
99.1 Press Release dated November 6, 1998.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GALILEO CORPORATION
Date: November 6, 1998 By: /s/ Josef W. Rokus
-------------------------------------
Josef W. Rokus
Vice President, Corporate Development
and Secretary
<PAGE> 4
EXHIBIT INDEX
EXHIBIT NO.
99.1 Press Release dated November 6, 1998.
<PAGE> 1
EXHIBIT 99.1
------------
Investor Relations: William T. Hanley (508) 347-4258
GALILEO ANNOUNCES TERMINATION OF DISCUSSIONS
TO SELL PRODUCT LINES
- -------------------------------------------------------------------------------
STURBRIDGE, MA, NOVEMBER 6, 1998 - Galileo Corporation (Nasdaq National Market:
GAEO) today announced the termination of discussions to sell certain product
lines in its Scientific Detector and Remote Spectroscopy Business because the
Company and the potential purchaser could not agree on the terms of the sale.
The Company had announced the signing of a non-binding Letter of Intent with an
undisclosed potential purchaser on August 19, 1998.
Because of the positive contribution of these product lines to its operating
results, the Company intends to continue to operate these lines, service
customers and continue product development programs as it had prior to the
initiation of these discussions.
Galileo, along with its wholly-owned subsidiaries, Leisegang Medical and OFC
Corporation, develops, manufactures and markets products based on its core
optical and photonic technologies for applications in women's health-related
medical products and instruments, analytical instruments, lenses and optical
filters, and office equipment. More information about the Company may be found
at its web sites www.galileocorp.com, www.ofccorp.com and www.leisegang.com.
